This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy Volunteers
and you are
between 18 and 65
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The study will evaluate the effect of different particle size of LY2140023. The study involves four single doses of 80 mg LY2140023 taken as 1 tablet by mouth with a washout period of at least 3 days between doses. This study will last approximately 60 days not including screening. Screening is required within 30 days prior to study entry.

Provided treatments

  • Drug: LY2140023 Monohydrate (Reference)
  • Drug: LY2140023 Monohydrate (Test - Low)
  • Drug: LY2140023 Monohydrate (Test - Medium)
  • Drug: LY2140023 Monohydrate (Test - High)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01591330. The sponsor of the trial is Eli Lilly and Company and it is looking for 35 volunteers for the current phase.
Official trial title:
A Particle Size Study of 3 Different Particle Size Test Tablet Formulations Compared to the Reference Tablet Formulation in Healthy Subjects